Description
Recombinant monoclonal antibody to CTGF. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma HL2180 (17-73-D6). This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.
Target
CTGF
Target Alias Names
CCN2, HCS24, IGFBP8, IBP-8, IGFBP-8, Connective Tissue Growth factor, CCN family member 2, Cellular communication network factor 2, Hypertrophic chondrocyte-specific protein 24, Insulin-like growth factor-binding protein 8, IGF-binding protein 8
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression